Skip to main content
Clinical Trials/EUCTR2005-004171-37-GB
EUCTR2005-004171-37-GB
Active, not recruiting
Phase 1

Oxidative Stress in children undergoing cardiopulmonary bypass: A trial of Sildenafil therapy

nited Bristol Healthcare Trust0 sites60 target enrollmentNovember 24, 2005

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Congenital Heart Disease
Sponsor
nited Bristol Healthcare Trust
Enrollment
60
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 24, 2005
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
nited Bristol Healthcare Trust

Eligibility Criteria

Inclusion Criteria

  • All infants less than one year of age sheduled to undergo cardiac surgery for congenital heart disease requiring cardiopulmonary bypass at the Bristol Royal Hospital for Children.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Children greater than one year of age.
  • Severe hypotension pre\-operatively.
  • Absence of or refusal of parental consent.
  • Infant already receiving sildenafil pre\-operatively.

Outcomes

Primary Outcomes

Not specified

Similar Trials